Catalyst Pharmaceutical Inc (NASDAQ: CPRX) has reported E.P.S. of $0.20 for its first fiscal quarter (ending March 31) versus $0.28 for the same period a year ago — a decline of -29%. Relative to the […]
Azenta Inc (NASDAQ: AZTA) has reported E.P.S. of $-2.47 for its second fiscal quarter (ending March 31) versus $-0.03 for the same period a year ago. Relative to the consensus estimate of $0.08, this was […]
Assembly Biosciences Inc (NASDAQ: ASMB) has reported E.P.S. of $-1.66 for its first fiscal quarter (ending March 31) versus $-0.37 for the same period a year ago. For the latest four quarters through March 31, […]
Ardmore Shipping Corp (NYSE: ASC) stock enjoyed a major increase of 15.6% on 5/8/24. The shares closed at $20.34. Moreover, this advance was accompanied by exceptionally high trading volume at 414% of normal. Relative to […]
For its first fiscal quarter (ending March 31), Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) has reported a 67% increase in E.P.S. from $0.54 a year ago to $0.90 in the current quarter. However, this performance was […]
On 5/8/24, American Public Education Inc (NASDAQ: APEI) stock enjoyed a major increase of 17.7%, closing at $17.87. Moreover, this advance was accompanied by exceptionally high trading volume at 281% of normal. The stock has […]
Ameresco Inc (NYSE: AMRC) stock closed at $26.94 on 5/8/24 after a major increase of 21.1%. Moreover, this advance was accompanied by exceptionally high trading volume at 265% of normal. The stock has risen 28.7% […]
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) has reported E.P.S. of $0.10 for its first fiscal quarter (ending March 31) versus $-0.27 for the same period a year ago. This performance was $-0.18 short of the consensus […]
For its first fiscal quarter (ending March 31), World Wrestling Entertainment In (NYSE: WWE) has reported a -357% decline in E.P.S. from $0.49 a year ago to $-1.26 in the current quarter. Recent Price Action […]
For its first fiscal quarter (ending March 31), Vital Energy Inc (NYSE: VTLE) has reported a -127% decline in E.P.S. from $6.93 a year ago to $-1.87 in the current quarter. This performance was $-4.51 […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research